Credit Agricole S A Regeneron Pharmaceuticals, Inc. Transaction History

Credit Agricole S A

$18.2 Billion
Q2 2024

A detailed history of Credit Agricole S A transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Agricole S A holds 9,418 shares of REGN stock, worth $9.54 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,418

Previous 8,673 8.59%

Holding current value

$9.54 Million

Previous $8.35 Million 18.58%

% of portfolio

0.05%

Previous 0.09%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $657,984 - $798,036	745 Added 8.59%	9,418 $9.9 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $3.15 Million - $3.47 Million	3,489 Added 67.3%	8,673 $8.35 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $999,207 - $1.14 Million	1,289 Added 33.09%	5,184 $4.55 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $179,344 - $218,691	259 Added 7.12%	3,895 $3.21 Million
Q2 2023 Jul 31, 2023	BUY	$700.03 - $830.35 $112,004 - $132,856	160 Added 4.6%	3,636 $2.61 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $138,819 - $168,701	204 Added 6.23%	3,476 $2.86 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $1.49 Million - $1.62 Million	-2,113 Reduced 39.24%	3,272 $2.36 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $1.56 Million - $1.97 Million	2,714 Added 101.61%	5,385 $3.71 Million
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $1.33 Million - $1.79 Million	2,418 Added 955.73%	2,671 $1.58 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $148,780 - $174,607	-250 Reduced 49.7%	253 $177,000
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $57,403 - $68,096	-100 Reduced 16.58%	503 $304,000
Q2 2021 Aug 10, 2021	SELL	$472.8 - $558.54 $39,242 - $46,358	-83 Reduced 12.1%	603 $337,000
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $134,019 - $164,460	300 Added 77.72%	686 $324,000
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $6.04 Million - $7.68 Million	-12,633 Reduced 97.04%	386 $187,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $327,939 - $396,242	602 Added 4.85%	13,019 $7.29 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $1.6 Million - $2.09 Million	3,250 Added 35.45%	12,417 $7.74 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $3.03 Million - $4.46 Million	9,019 Added 6093.92%	9,167 $4.48 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $14,380 - $19,911	48 Added 48.0%	148 $46,000
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $28,460 - $34,499	100 New	100 $34,000
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $17 Million - $22.2 Million	-47,332 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $9.32 Million - $10.9 Million	21,614 Added 84.04%	47,332 $21.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	25,718	25,718 $12.6 Million

Others Institutions Holding REGN

# of Institutions

1,464

Shares Held

84.4M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $109B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.

Account

Credit Agricole S A Regeneron Pharmaceuticals, Inc. Transaction History